GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemiaAdriano Venditti, Sergio Amadori, Agostino Tafuri et al.|Blood|2019Cited by 215
Evaluation of the Practice of Antifungal Prophylaxis Use in Patients With Newly Diagnosed Acute Myeloid Leukemia: Results From the SEIFEM 2010-B RegistryLivio Pagano, Franco Aversa, Lorella Melillo et al.|Clinical Infectious Diseases|2012Cited by 83